
Dassiet (Onbone)
Creating sustainable mobility for humans and animals.
Date | Investors | Amount | Round |
---|---|---|---|
€10.0m | Late VC | ||
Total Funding | 000k |
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | (13 %) | 14 % | 68 % | (25 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (373 %) | (74 %) | (230 %) | (231 %) | (134 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Onbone operates in the medical device industry, specializing in the development and distribution of Woodcast, an innovative splinting material. The company serves orthopedic practitioners and healthcare facilities, providing a non-toxic, mouldable, and remouldable solution for splinting needs. Woodcast is environmentally friendly and does not require water or gloves for application, making it a convenient and safe option for both practitioners and patients. The business model revolves around the sale of Woodcast materials and related accessories, generating revenue through direct sales to hospitals, clinics, and medical professionals. Onbone's market includes healthcare providers looking for efficient, safe, and sustainable splinting solutions. The company differentiates itself with its focus on health safety, ease of use, and environmental sustainability.
Keywords: splinting material, non-toxic, mouldable, remouldable, orthopedic, healthcare, sustainable, easy application, medical device, environmental benefits.